Higher dosage of the epidermal growth factor receptor mutant allele in lung adenocarcinoma correlates with younger age, stage IV at presentation, and poorer survival.
about
Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survivalKRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreasKRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer.The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma.EGFR mutation detection by microfluidic technology: a validation study.Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients.
P2860
Q28258483-8DCD38E0-BF1A-42B4-9092-2C8969078955Q28289209-D89C45DB-FBB6-4056-8C48-5B33A743D71EQ35547005-BDEB86B2-71AB-4307-98A0-0286A578A29CQ35654769-C047FBD8-2F3E-489D-9E48-6C49E7D808F3Q36906563-6F38970D-DCE0-4AA0-908C-0D9FA02E6665Q39136032-AFEFF378-0CC3-44DC-BF4B-73615069CA27Q47164988-2190A0A2-F898-4552-867F-896E33A4D579Q52332839-47B02114-BA1F-4B3B-B9CB-72BA4054DD72
P2860
Higher dosage of the epidermal growth factor receptor mutant allele in lung adenocarcinoma correlates with younger age, stage IV at presentation, and poorer survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Higher dosage of the epidermal ...... entation, and poorer survival.
@en
Higher dosage of the epidermal ...... entation, and poorer survival.
@nl
type
label
Higher dosage of the epidermal ...... entation, and poorer survival.
@en
Higher dosage of the epidermal ...... entation, and poorer survival.
@nl
prefLabel
Higher dosage of the epidermal ...... entation, and poorer survival.
@en
Higher dosage of the epidermal ...... entation, and poorer survival.
@nl
P1476
Higher dosage of the epidermal ...... sentation, and poorer survival
@en
P2093
Gerard J Oakley
P304
P356
10.1097/JTO.0B013E31821D41AF
P577
2011-08-01T00:00:00Z